Company Filing History:
Years Active: 2018
Title: Innovator Spotlight: Elana Ben Moha-Lerman
Introduction: Elana Ben Moha-Lerman is a talented inventor based in Ono, Israel. She has made significant contributions to the pharmaceutical field, particularly through her groundbreaking work on Ibrutinib, a medication used to treat certain types of cancer. As a member of the research team at Teva Pharmaceuticals USA, Inc., Elana's innovative ideas have the potential to impact patient care positively.
Latest Patents: Elana holds a patent for solid-state forms of Ibrutinib, specifically forms G, J, and K, along with the pharmaceutical compositions that contain them. This invention signifies a remarkable advancement in the formulation of Ibrutinib, enhancing its stability and efficacy.
Career Highlights: Throughout her career, Elana has demonstrated exceptional expertise in pharmaceutical innovations. Her dedication to research and development at Teva Pharmaceuticals showcases her commitment to improving medical treatments and patient outcomes. Her sole patent reflects her innovative thinking and her contributions to the field.
Collaborations: Elana has collaborated with esteemed colleagues, including Meital Cohen and Yuval Cohen. Together, their combined knowledge and skills have fostered a creative environment for innovation, leading to the development of new pharmaceutical advancements.
Conclusion: Elana Ben Moha-Lerman stands out as a noteworthy inventor in the pharmaceutical industry. Her work on solid-state forms of Ibrutinib places her among the ranks of innovative thinkers who strive to enhance healthcare solutions. With her talent and collaboration, the future of pharmaceutical advancements looks promising.